Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nintedanib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01441297
What this trial is testing

BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerSmall Cell Lung Cancer Recurrent
Ji-youn Han 24
Testing effectiveness (Phase 2)Study completedNCT03292250
What this trial is testing

Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]

Who this might be right for
HNSCCHead and Neck Neoplasms
Seoul National University Hospital 180
Post-approval studies (Phase 4)Study completedNCT02606877
What this trial is testing

Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 37
Large-scale testing (Phase 3)Study completedNCT03820726
What this trial is testing

A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 435
Early research (Phase 1)Study completedNCT02182154
What this trial is testing

Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 8
Early research (Phase 1)Study completedNCT01346540
What this trial is testing

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 16
Testing effectiveness (Phase 2)Study completedNCT04046614
What this trial is testing

Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology

Who this might be right for
Adenocarcinoma of the Lung
AIO-Studien-gGmbH 56
Not applicableNo Longer AvailableNCT05624281
What this trial is testing

A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)

Who this might be right for
Lung Diseases, Interstitial (in Pediatric Populations)Childhood Interstitial Lung Disease (chILD)
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT02308553
What this trial is testing

Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma

Who this might be right for
Cutaneous Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 33
Not applicableStudy completedNCT02607722
What this trial is testing

All-Case Surveillance of Ofev in Patients With IPF in Japan

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 10,117
Not applicableActive Not RecruitingNCT06714812
What this trial is testing

Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib

Who this might be right for
IPF
IRCCS Azienda Ospedaliero-Universitaria di Bologna 100
Post-approval studies (Phase 4)Ended earlyNCT03717012
What this trial is testing

Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 19
Testing effectiveness (Phase 2)Ended earlyNCT02389764
What this trial is testing

Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)UnknownNCT02558387
What this trial is testing

Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck

Who this might be right for
Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck
Samsung Medical Center 20
Early research (Phase 1)Study completedNCT02835833
What this trial is testing

Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Who this might be right for
Renal Cell CarcinomaColorectal AdenocarcinomaNon-squamous Non-small Cell Lung Cancer+2 more
University of Alabama at Birmingham 21
Testing effectiveness (Phase 2)Study completedNCT02182063
What this trial is testing

A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Boehringer Ingelheim 81
Early research (Phase 1)Study completedNCT02182141
What this trial is testing

An Dose Escalation Study of BIBF 1120 Administered in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Boehringer Ingelheim 17
Not applicableStudy completedNCT03710824
What this trial is testing

Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 180
Not applicableStudy completedNCT03104322
What this trial is testing

Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
patientMpower Ltd. 7
Testing effectiveness (Phase 2)WithdrawnNCT02856867
What this trial is testing

Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)

Who this might be right for
Esophagogastric AdenocarcinomaMetastatic DiseaseNo Previous Chemotherapy for Metastatic Esophagogastric Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Next Page